MedPath

Ganglionated Plexi Ablation Combined With Pulmonary Vein Isolation

Phase 2
Completed
Conditions
Persistent Atrial Fibrillation
Interventions
Procedure: Pulmonary vein isolation
Procedure: Linear Lesion Ablation
Procedure: Ganglionated plexi ablation
Registration Number
NCT01703247
Lead Sponsor
Meshalkin Research Institute of Pathology of Circulation
Brief Summary

The investigators have conducted a prospective, double-blind, randomized study to assess the comparative safety and efficacy of two different ablation strategies, PVI plus linear lesions (LL) versus PVI plus GP ablation, in patients with persistent or longstanding persistent AF. Results were assessed after follow-up of at least 3 years with the use of an implanted monitoring device (IMD).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
264
Inclusion Criteria
  • Persistent and longstanding persistent AF
Exclusion Criteria
  • congestive heart failure
  • LV ejection fraction < 35%
  • left atrial diameter > 60 mm

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PVI+LLPulmonary vein isolationCircumferential PVI was accomplished and then additional ablation lines were created by connecting the left inferior PV to the mitral annulus (mitral isthmus) and the LA between the two superior PVs (roof). Finally, patients underwent cavo-tricuspid isthmus ablation in the right atrium.
PVI+LLLinear Lesion AblationCircumferential PVI was accomplished and then additional ablation lines were created by connecting the left inferior PV to the mitral annulus (mitral isthmus) and the LA between the two superior PVs (roof). Finally, patients underwent cavo-tricuspid isthmus ablation in the right atrium.
PVI+GPPulmonary vein isolationTo accomplish ganglionated plexi ablation, LA target sites were identified as the anatomic locations where vagal reflexes were evoked by transcatheter high-frequency stimulation (HFS). Rectangular electrical stimuli were delivered at a frequency of 20-50 Hz, output amplitude 15 V and pulse duration of 10 ms, for 5 sec (Stimulator B-53, Biotok Inc, Russia).
PVI+GPGanglionated plexi ablationTo accomplish ganglionated plexi ablation, LA target sites were identified as the anatomic locations where vagal reflexes were evoked by transcatheter high-frequency stimulation (HFS). Rectangular electrical stimuli were delivered at a frequency of 20-50 Hz, output amplitude 15 V and pulse duration of 10 ms, for 5 sec (Stimulator B-53, Biotok Inc, Russia).
Primary Outcome Measures
NameTimeMethod
freedom of atrial tachyarrhythmia, including AF and atrial flutter/tachycardia3 years
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

State Research Institute of CIrculation Pathology

🇷🇺

Novosibirsk, Russian Federation

© Copyright 2025. All Rights Reserved by MedPath